Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Diabetes Care
|
May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Avivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Care
|
November 1, 2016
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Ofri Mosenzon, Gil Leibowitz, Deepak L Bhatt, et al.
Diabetes Care
|
March 12, 2015
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial
Lawrence A Leiter, Hwee Teoh, Eugene Braunwald, et al.
Diabetes, Obesity & Metabolism
|
April 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis
Jan Oscarsson, Monika Huhn, Yunyun Jiang, et al.
JAMA Cardiology
|
July 20, 2022
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Kazuma Oyama, Itamar Raz, Avivit Cahn, et al.
Journal of Diabetes and Its Complications
|
November 29, 2025
Current primary care approaches to diabetic foot prevention and treatment
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Asma Ahmed, et al.
Diabetes/Metabolism Research and Reviews
|
May 15, 2018
Global status of diabetes prevention and prospects for action: A consensus statement
Mahmoud Ibrahim, Jaakko Tuomilehto, Pablo Aschner, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters
Omer Bar Ziv, Avivit Cahn, Tallulah Jansen, et al.
Diabetes, Obesity & Metabolism
|
February 25, 2020
Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial
Harpreet S Bajaj, Itamar Raz, Ofri Mosenzon, et al.
Diabetes/Metabolism Research and Reviews
|
April 29, 2020
Hypoglycaemia and its management in primary care setting
Mahmoud Ibrahim, Jason Baker, Avivit Cahn, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Diabetes Care
|
May 26, 2016
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Avivit Cahn, Itamar Raz, Ofri Mosenzon, et al.
Diabetes Care
|
November 1, 2016
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Ofri Mosenzon, Gil Leibowitz, Deepak L Bhatt, et al.
Diabetes Care
|
March 12, 2015
Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial
Lawrence A Leiter, Hwee Teoh, Eugene Braunwald, et al.
Diabetes, Obesity & Metabolism
|
April 28, 2026
Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis
Jan Oscarsson, Monika Huhn, Yunyun Jiang, et al.
JAMA Cardiology
|
July 20, 2022
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Kazuma Oyama, Itamar Raz, Avivit Cahn, et al.
Journal of Diabetes and Its Complications
|
November 29, 2025
Current primary care approaches to diabetic foot prevention and treatment
Mahmoud Ibrahim, Ebtesam M Ba-Essa, Asma Ahmed, et al.
Diabetes/Metabolism Research and Reviews
|
May 15, 2018
Global status of diabetes prevention and prospects for action: A consensus statement
Mahmoud Ibrahim, Jaakko Tuomilehto, Pablo Aschner, et al.
The Journal of Infectious Diseases
|
April 1, 2024
Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living With Human Immunodeficiency Virus: Evaluation of Clinical and Microbiome Parameters
Omer Bar Ziv, Avivit Cahn, Tallulah Jansen, et al.
Diabetes, Obesity & Metabolism
|
February 25, 2020
Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial
Harpreet S Bajaj, Itamar Raz, Ofri Mosenzon, et al.
Diabetes/Metabolism Research and Reviews
|
April 29, 2020
Hypoglycaemia and its management in primary care setting
Mahmoud Ibrahim, Jason Baker, Avivit Cahn, et al.
Page
of 10